Introduction
============

Chronic kidney disease (CKD) is common in the elderly.[@b1-cia-8-1387] Glomerular filtration rate (GFR) is the best index of overall kidney function.[@b2-cia-8-1387] In two previous studies,[@b3-cia-8-1387],[@b4-cia-8-1387] we found that creatinine-based GFR predicting equations were not suitable for elderly Chinese patients with CKD. In the present study several improvements to study design were made. First, cystatin C was added as a new predicting variable, and was traceable to standard reference material for cystatin C measurement. Second, GFR was measured by the technetium-99m diethylene-triamine-penta-acetic acid (^99m^Tc-DTPA) renal dynamic imaging method, and was calibrated equally to the dual plasma sample ^99m^Tc-DTPA-GFR. Third, sample size was increased. We aimed to evaluate the performance of the new CKD Epidemiology Collaboration (CKD-EPI) creatinine--cystatin C equation[@b5-cia-8-1387] in a cohort of elderly Chinese participants, compared with the creatinine-based equations.

Materials and methods
=====================

Participants
------------

Participants aged 60 years or older in the Third Affiliated Hospital of Sun Yat-sen University, People's Republic of China were enrolled between January 2010 and December 2012. Exclusion criteria included: 1) acute kidney function deterioration, edema, skeletal muscle atrophy, pleural effusion or ascites, malnutrition, amputation, heart failure, and ketoacidosis, or 2) on cimetidine or trimethoprim, or 3) being treated with dialysis at the time of the study. Study approval was obtained from the institutional review board at the Third Affiliated Hospital of Sun Yat-sen University. Informed consent of subjects was obtained prior to the beginning of the study.

Laboratory methods
------------------

GFR was measured by the ^99m^Tc-DTPA renal dynamic imaging method,^67^ as described previously[@b8-cia-8-1387] According to the method developed by Ma et al,[@b9-cia-8-1387] we determined the minimum sample size to be 36 (95% confidence interval and 80% power), using Open Epi Version 2 (<http://www.openepi.com>)[@b10-cia-8-1387] to compare means (in order to ensure that our measured GFR \[mGFR\] values were calibrated equally to the dual plasma sample ^99m^Tc-DTPA-GFR). Calculation was based on the findings in a previous Chinese study[@b11-cia-8-1387] We randomly selected 36 cases (GFR measured by the DTPA renal dynamic imaging method, range 15.6--106.3 mL/minute/1.73 m^2^) and performed the dual plasma samples method ^99m^Tc-DTPA clearance simultaneously with the renal dynamic imaging. After image acquisition, blood samples were taken 2 and 4 hours after injection from the opposite forearm. The plasma was separated, and radioactivity was counted in a multi-function well counter (ZD-6000 multi-function instrument; Zhida Technology Company, Xian, People's Republic of China).[@b12-cia-8-1387] The ^99m^Tc-DTPA renal dynamic imaging GFR measured in our study can be calibrated to dual plasma samples ^99m^Tc-DTPA clearance GFR using a linear regression equation:
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Serum creatinine level was measured by the enzymatic method on a Hitachi 7180 AutoAnalyzer (Hitachi Ltd, Tokyo, Japan; reagents from Roche Diagnostics, Mannheim, Germany), and recalibrated to isotope dilution mass spectrometry. Serum cystatin C assays were traceable to the certified reference materials (ERM-DA471). Performance of the CKD-EPI creatinine--cystatin C equation was compared with the Cockcroft--Gault equation,[@b13-cia-8-1387] the re-expressed 4-variable Modification of Diet in Renal Disease (MDRD) equation,[@b14-cia-8-1387] and the CKD-EPI creatinine equation[@b15-cia-8-1387] ([Table 1](#t1-cia-8-1387){ref-type="table"}).

Statistical analyses
--------------------

Bias was defined as the median of the difference between the mGFR and estimated GFR, and precision was measured by the interquartile range (IQR) for the difference. Accuracy was defined by both the median of the absolute difference and percentage of estimated GFR not deviating more than 30% from the mGFR. The Wilcoxon signed-rank test was used for difference, the bootstrap method[@b16-cia-8-1387] for IQR, and the McNemar test for 30% accuracy. Performances of the GFR estimating equations were assessed by three aspects, including bias, precision, and accuracy. An optimal score system[@b4-cia-8-1387] was developed. The equation that performed the best in each aspect in the entire cohort was scored as 1, and in each GFR subgroup as 0.5. The greater total scores, the better synthetic performance. All calculations and statistics were performed using SPSS software (version 11.0; IBM Corporation, Armonk, NY, USA) and Matlab software (version 2011b; The Mathworks, Boston, MA, USA).

Results
=======

A total of 431 participants aged 60 years or older were enrolled. The mean age was 69.9 ± 6.8 years and the mean mGFR was 53.4 ± 26.9 mL/minute/1.73 m^2^. Detailed characteristics are listed in [Table 2](#t2-cia-8-1387){ref-type="table"}.

Although the bias of the CKD-EPI creatinine--cystatin C equation was greater than with the other equations (median difference, 5.7 mL/minute/1.73 m^2^ versus 0.4--2.5 mL/minute/1.73 m^2^, *P*\<0.001 for all comparisons), the precision was improved with the CKD-EPI creatinine--cystatin C equation (IQR for the difference, 19.5 mL/minute/1.73 m^2^ versus 23.0--23.6 mL/minute/1.73 m^2^, *P*\<0.001 for all comparisons), leading to slight improvement in accuracy (median absolute difference, 10.5 mL/minute/1.73 m^2^ versus 12.2 and 11.4 mL/minute/1.73 m^2^ for the Cockcroft--Gault equation and the re-expressed 4-variable MDRD equation, *P*=0.04 for both; and 11.6 mL/minute/1.73 m^2^ for the CKD-EPI creatinine equation, *P*=0.11); 30% accuracy, 59.9% versus 55.5%--57.5%, *P*\>0.05 for all ([Table 3](#t3-cia-8-1387){ref-type="table"}). An optimal score system was developed to evaluate the performances between different equations ([Table 4](#t4-cia-8-1387){ref-type="table"}). The CKD-EPI creatinine--cystatin C equation achieved the optimal scores (6.0 versus a range from 1.0--2.0 for the other equations).

We used multiple regression analysis to determine the factors that affected the accuracy of the CKD-EPI creatinine--cystatin C equation, with 30% accuracy of the CKD-EPI creatinine--cystatin C equation as the dependent variable and GFR categories (category 1: 1; category 2; 2: category 3; 3: category 4; 4: category 5; 5), age (≤65 years: 1; \>65 years: 2), sex (male: 1; female: 2), diabetes (non-diabetic: 1; diabetes: 2), body mass index (\<20 kg/m^2^: 1; ≥20 kg/m^2^ and \<25 kg/m^2^: 2; ≥25 kg/m^2^ and ≤30 kg/m^2^: 3; \>30 kg/m^2^: 4) as the independent variables for regression analysis. We found that both higher GFR category and diabetes were independent factors that negatively correlated with 30% accuracy of the CKD-EPI creatinine-cystatin C equation (β=−0.184 and −0.113, *P*\<0.001 and *P*=0.02, respectively).

Discussion
==========

Recently, measurement of serum cystatin C has been advocated as a simple, reliable, and accurate marker of GFR.[@b17-cia-8-1387] Cystatin C is a low molecular weight protein that is freely filtered across the glomerular barrier and almost completely reabsorbed and catabolized by tubular cells.[@b17-cia-8-1387] A cystatin-C-based equation has many advantages over a creatinine-based one in the assessment of renal function in the elderly, since the creatinine-based one can be affected by a reduced muscle mass and other confounding factors such as age, race, sex, diabetes, and day-to-day variables. However, there is still no explicit evidence for superiority in this population in clinical practice.[@b18-cia-8-1387],[@b19-cia-8-1387] Furthermore, a cystatin-C-based estimation of GFR also showed only limited improvement in contrast to a creatinine-based formula.[@b18-cia-8-1387] In 2012, a new CKD-EPI creatinine--cystatin C equation was developed based on both serum cystatin C and creatinine. The combined equation performed better than equations based on either marker alone.[@b5-cia-8-1387] However, the CKD-EPI creatinine--cystatin C equation has not been validated in the elderly. The current study was designed to evaluate its performance in GFR estimation for the elderly Chinese population.

In this study, we found that although the bias of the CKD-EPI creatinine--cystatin C equation was greater than the other creatinine-based equations, the precision was improved with the CKD-EPI creatinine--cystatin C equation, leading to slight improvement in accuracy and the optimal scores of performance as well. Both higher GFR category and diabetes were independent factors negatively correlated with the 30% accuracy of the CKD-EPI creatinine--cystatin C equation. These results confirmed that the combination of novel filtration markers, such as cystatin C and serum creatinine, into the GFR estimating formula may be a key to improving accuracy.

There were some limitations to this study. First, subjects represented a specific elderly cohort in the People's Republic of China; further validations in other age or racial populations are needed. Second, the difference in the measurement of GFR introduced systemic bias.[@b20-cia-8-1387] Third, GFR estimating equation may be influenced by the difference of mGFR distribution and the cause of disease in the development population.[@b21-cia-8-1387]

In summary, comparing the creatinine-based equations, the CKD-EPI creatinine--cystatin C equation is more suitable for the elderly Chinese population. However, the cost-effectiveness of the CKD-EPI creatinine--cystatin C equation for clinical use should be considered.
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###### 

GFR predicting equations

  Basis of equation and sex                                     Serum creatinine   CYC     Equation for estimating GFR
  ------------------------------------------------------------- ------------------ ------- -----------------------------------------------------------------------------------
  **Cockcroft--Gault equation**[@b13-cia-8-1387]                                           
                                                                                           (140 − Age) × Weight ÷ SC ÷ 72 × \[0.85 if female\] × 1.73 ÷ BsA
  **Re-expressed 4-variable MDRD equation**[@b14-cia-8-1387]                               
                                                                                           175 × SC^−1.154^ × Age^−0.203^ × \[0.742 if female\] × \[1.212 if Black\]
  **CKD-EPI creatinine equation**[@b15-cia-8-1387]                                         
  Female                                                        ≤0.7                       144 × (SC ÷ 0.7)^−0.329^ × 0.993^Age^ \[× 1.159 if Black\]
  Female                                                        \>0.7                      144 × (SC ÷ 0.7)^−1.209^ × 0.993^Age^ \[× 1.159 if Black\]
  Male                                                          ≤0.9                       141 × (SC ÷ 0.9)^−0.411^ × 0.993^Age^ \[× 1.159 if Black\]
  Male                                                          \>0.9                      141 × (SC ÷ 0.9)^−1.209^ × 0.993^Age^ \[× 1.159 if Black\]
  **CKD-EPI creatinine--cystatin C equation**[@b5-cia-8-1387]                              
  Female                                                        ≤0.7               ≤0.8    130 × (SC ÷ 0.7)^−0.248^ × (CYC ÷ 0.8)^−0.375^ × (0.995)^Age^ × \[1.08 if Black\]
                                                                                   \>0.8   130 × (SC ÷ 0.7)^−0.248^ × (CYC ÷ 0.8)^−0.711^ × (0.995)^Age^ × \[1.08 if Black\]
  Female                                                        \>0.7              ≤0.8    130 × (SC ÷ 0.7)^−0.601^ × (CYC ÷ 0.8)^−0.375^ × (0.995)^Age^ × \[1.08 if Black\]
                                                                                   \>0.8   130 × (SC ÷ 0.7)^−0.601^ × (CYC ÷ 0.8)^−0.711^ × (0.995)^Age^ × \[1.08 if Black\]
  Male                                                          ≤0.9               ≤0.8    135 × (SC ÷ 0.9)^−0.207^ × (CYC ÷ 0.8)^−0.375^ × (0.995)^Age^ × \[1.08 if Black\]
                                                                                   \>0.8   135 × (SC ÷ 0.9)^−0.207^ × (CYC ÷ 0.8)^−0.711^ × (0.995)^Age^ × \[1.08 if Black\]
  Male                                                          \>0.9              ≤0.8    135 × (SC ÷ 0.9)^−0.601^ × (CYC ÷ 0.8)^−0.375^ × (0.995)^Age^ × \[1.08 if Black\]
                                                                                   \>0.8   135 × (SC ÷ 0.9)^−0.601^ × (CYC ÷ 0.8)^−0.711^ × (0.995)^Age^ × \[1.08 if Black\]

**Abbreviations:** BSA, body surface area; CYC, cystatin C; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; GFR, glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; SC, serum creatinine.

###### 

Participants, characteristics[\*](#tfn2-cia-8-1387){ref-type="table-fn"}

  ------------------------------------ -------------
  Subjects (n)                         431
  Age (year)                           69.9 ± 6.8
  Male sex (n \[%\])                   233 (54.1)
  Diabetes (n \[%\])                   263 (61.0)
  Body mass index (kg/m^2^)            24.2 ± 4.3
  Body surface area (m^2^)             1.66 ± 0.19
  Serum creatinine (mg/dL)             2.0 ± 1.9
  Serum cystatin C (mg/dL)             2.0 ± 1.2
  Measured GFR (mL/minute/1.73 m^2^)   53.4 ± 26.9
  GFR categories                       
   \<15 (mL/minute/1.73 m^2^)          33 (7.7)
   15--29 (mL/minute/1.73 m^2^)        59 (13.7)
   30--59 (mL/minute/1.73 m^2^)        174 (40.4)
   60--89 (mL/minute/1.73 m^2^)        118 (27.4)
   \>90 (mL/minute/1.73 m^2^)          47 (10.9)
  ------------------------------------ -------------

**Note:**

Plus-minus values are means ± standard deviation.

**Abbreviation:** GFR, glomerular filtration rate.

###### 

Performance between measured GFR and estimated GFR

  Variable                                                    Measured GFR (mL/minute/1.73 m^2^)                                                                                                                    
  ----------------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- -------------------------------------------------
  Bias -- median difference (mL/minute/1.73 m^2^)                                                                                                                                                                   
   Cockcroft--Gault equation                                  2.5[\*](#tfn4-cia-8-1387){ref-type="table-fn"}    1.0[\*](#tfn4-cia-8-1387){ref-type="table-fn"}    3.3[\*](#tfn4-cia-8-1387){ref-type="table-fn"}    2.6[\*](#tfn4-cia-8-1387){ref-type="table-fn"}
   Re-expressed 4-variable MDRD equation                      0.4[\*](#tfn4-cia-8-1387){ref-type="table-fn"}    2.0[\*](#tfn4-cia-8-1387){ref-type="table-fn"}    1.1[\*](#tfn4-cia-8-1387){ref-type="table-fn"}    −4.2[\*](#tfn4-cia-8-1387){ref-type="table-fn"}
   CKD-EPI creatinine equation                                0.5[\*](#tfn4-cia-8-1387){ref-type="table-fn"}    2.7[†](#tfn5-cia-8-1387){ref-type="table-fn"}     −0.4[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   −0.7[\*](#tfn4-cia-8-1387){ref-type="table-fn"}
   CKD-EPI creatinine--cystatin C equation                    5.7                                               3.1                                               6.2                                               6.8
  Precision -- IQR for the difference (mL/minute/1.73 m^2^)                                                                                                                                                         
   Cockcroft--Gault equation                                  23.6[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   11.4[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   22.9[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   31.7[\*](#tfn4-cia-8-1387){ref-type="table-fn"}
   Re-expressed 4-variable MDRD equation                      23.6[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   12.6[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   23.7[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   30.5[\*](#tfn4-cia-8-1387){ref-type="table-fn"}
   CKD-EPI creatinine equation                                23.0[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   11.7[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   25.7[\*](#tfn4-cia-8-1387){ref-type="table-fn"}   28.3[\*](#tfn4-cia-8-1387){ref-type="table-fn"}
   CKD-EPI creatinine--cystatin C equation                    19.5                                              8.8                                               22.4                                              24.6
  **Accuracy**                                                                                                                                                                                                      
  Median absolute difference (mL/minute/1.73 m^2^)                                                                                                                                                                  
   Cockcroft--Gault equation                                  12.2[‡](#tfn6-cia-8-1387){ref-type="table-fn"}    5.7                                               13.2                                              16.8[†](#tfn5-cia-8-1387){ref-type="table-fn"}
   Re-expressed 4-variable MDRD equation                      11.4[‡](#tfn6-cia-8-1387){ref-type="table-fn"}    6.4[‡](#tfn6-cia-8-1387){ref-type="table-fn"}     11.9                                              16.0
   CKD-EPI creatinine equation                                11.6                                              7.0[†](#tfn5-cia-8-1387){ref-type="table-fn"}     12.7                                              14.0
   CKD-EPI creatinine--cystatin C equation                    10.5                                              6.0                                               12.7                                              12.2
  30% accuracy (%)                                                                                                                                                                                                  
   Cockcroft--Gault equation                                  57.5                                              37.0                                              52.3                                              74.5
   Re-expressed 4-variable MDRD equation                      57.5                                              37.0                                              55.7                                              74.5
   CKD-EPI creatinine equation                                55.5                                              35.9                                              48.9                                              74.5
   CKD-EPI creatinine--cystatin C equation                    59.9                                              40.2                                              51.7                                              79.4

**Notes:**

*P*\<0.001 compared with the CKD-EPI creatinine--cystatin C equation GFR

*P*\<0.01 compared with the CKD-EPI creatinine--cystatin C equation GFR

*P*\<0.05 compared with the CKD-EPI creatinine--cystatin C equation GFR.

**Abbreviations:** CKD-EPI, Chronic Kidney Disease epidemiology Collaboration; GFR, glomerular filtration rate; IQR, interquartile range; MDRD, Modification of Diet in Renal Disease.

###### 

Optimal scores[\*](#tfn8-cia-8-1387){ref-type="table-fn"} by equation

  Equation                                  Total scores
  ----------------------------------------- --------------
  Cockcroft--Gault equation                 1.0
  Re-expressed 4-variable MDRD equation     2.0
  CKD-EPI creatinine equation               1.0
  CKD-EPI creatinine--cystatin C equation   6.0

**Note:**

The equation which performed the best overall scored 1, and in each GFR subgroup scored 0.5.

**Abbreviations:** CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; GFR, glomerular filtration rate; MDRD, Modification of Diet in Renal Disease.

[^1]: \*These authors contributed equally to the paper
